全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用：99美元
投递稿件

为什么选择我们？ >>
- 开源期刊
- 同行审议
- 快速出刊
- 终身存储
- 免费检索
- 免费推广
- 更多...
- 搜索引擎

Integrated Blood Pressure Control

ISSN Print: 1178-7104

ISSN Online:

主页: https://www.dovepress.com/integrated-blood-pressure-control-journal

分享:




Go

Cardio-ankle vascular index (CAVI) as an indicator of arterial stiffness

Sun CK

Current perspectives on rosuvastatin

Hu M,Tomlinson B

Efficacy and tolerability of a single-pill combination of telmisartan 80 mg and hydrochlorothiazide 25 mg according to age, gender, race, hypertension severity, and previous antihypertensive use: planned analyses of a randomized trial

Zhu D,Bays H,Gao P,Mattheus M

New treatment options in the management of hypertension: appraising the potential role of azilsartan medoxomil

Volpe M, Savoia C

Out-of-office blood pressure: from measurement to control

Baguet JP

Cardio classics revisited: focus on the role of amlodipine

Owen AJ, Reid CM

Efficacy and safety of prolonged-release melatonin for insomnia in middle-aged and elderly patients with hypertension: a combined analysis of controlled clinical trials

Lemoine P, Wade AG, Katz A, Nir T, Zisapel N

Cardio classics revisited: focus on the role of amlodipine

Owen AJ,Reid CM

Efficacy and safety of prolonged-release melatonin for insomnia in middle-aged and elderly patients with hypertension: a combined analysis of controlled clinical trials

Lemoine P,Wade AG,Katz A,Nir T

Out-of-office blood pressure: from measurement to control

Baguet JP

New treatment options in the management of hypertension: appraising the potential role of azilsartan medoxomil

Volpe M,Savoia C

Long-term use and tolerability of irbesartan for control of hypertension

Forni V, Wuerzner G, Pruijm M, Burnier M

Clinical utility of fixed-combination telmisartan–amlodipine in the treatment of hypertension

Segura J, Ruilope LM

Integrated control of hypertension by olmesartan medoxomil and hydrochlorothiazide and rationale for combination

Punzi HA

Combining antihypertensive and antihyperlipidemic agents – optimizing cardiovascular risk factor management

Zamorano J, Edwards J

Short- and long-term physiologic and pharmacologic control of blood pressure in pediatric patients

Trachtman H

Hypertension and other morbidities with Cushing’s syndrome associated with corticosteroids: a review

Melpomeni Peppa, Maria Krania, Sotirios A Raptis

Challenges posed to the maternal circulation by pregnancy

Valdés G, Corthorn J

A critical appraisal of the clinical effectiveness of a fixed combination of valsartan, amlodipine, and hydrochlorothiazide in achieving blood pressure goals

Cheryl L Laffer, Fernando Elijovich

A critical appraisal of the clinical effectiveness of a fixed combination of valsartan, amlodipine, and hydrochlorothiazide in achieving blood pressure goals

Cheryl L Laffer,Fernando Elijovich

Hypertension and other morbidities with Cushing’s syndrome associated with corticosteroids: a review

Melpomeni Peppa,Maria Krania,Sotirios A Raptis

Combining antihypertensive and antihyperlipidemic agents – optimizing cardiovascular risk factor management

Zamorano J,Edwards J

Long-term use and tolerability of irbesartan for control of hypertension

Forni V,Wuerzner G,Pruijm M,Burnier M

Integrated control of hypertension by olmesartan medoxomil and hydrochlorothiazide and rationale for combination

Punzi HA

Clinical utility of fixed-combination telmisartan–amlodipine in the treatment of hypertension

Segura J,Ruilope LM

Challenges posed to the maternal circulation by pregnancy

Valdés G,Corthorn J

Short- and long-term physiologic and pharmacologic control of blood pressure in pediatric patients

Trachtman H

First-line treatment of hypertension: critical appraisal of potential role of aliskiren and hydrochlorothiazide in a fixed combination

Konstantinos Savvatis, Dirk Westermann, Heinz-Peter Schultheiss, et al

Critical appraisal and pooled analysis of telmisartan alone or in combination with hydrochlorothiazide for achieving blood pressure goals

Satoshi Morimoto, Nobuyuki Takahashi, Tatsuyori Morita, et al

Endothelial function, blood pressure control, and risk modification: impact of irbesartan alone or in combination

Giuseppe Derosa, Sibilla AT Salvadeo

Safety and tolerability of fixed antihypertensive combinations in blood pressure control: focus on olmesartan medoxomil and amlodipine combination

Ijlal Uddin, Shakil Aslam

Impact of telmisartan in modifying vascular risk

Jean-Philippe Baguet, Olivier Ormezzano, Gilles Barone-Rochette

Is tetrahydrobiopterin a therapeutic option in diabetic hypertensive patients?

Alberto Francisco Rubio-Guerra, Hilda Vargas-Robles, Luz Maria Ramos-Brizuela, et al

Complementary mechanisms of action and rationale for the fixed combination of perindopril and indapamide in treating hypertension – update on clinical utility

Vivencio Barrios, Carlos Escobar

De-stiffening drug therapy and blood pressure control

Michel E Safar

Update on the role of candesartan in the optimal management of hypertension and cardiovascular risk reduction

Ikechi G Okpechi, Brian L Rayner

Evidence-based approach for managing hypertension in type 2 diabetes

Gerti Tashko, Robert A Gabbay

Fixed combinations in the pragmatic management of hypertension: focus on aliskiren and hydrochlorothiazide as a single pill

Michel Burnier

Critical appraisal of amlodipine and olmesartan medoxomil fixed-dose combination in achieving blood pressure goals

Jan Basile

Impact of olmesartan on blood pressure, endothelial function, and cardiovascular outcomes

Eduardo Pimenta, Suzanne Oparil

Optimal management of hypertension in elderly patients

Maria Czarina Acelajado

Critical appraisal of the differential effects of antihypertensive agents on arterial stiffness

Francesca Kum, Janaka Karalliedde

Renoprotection, renin inhibition, and blood pressure control: the impact of aliskiren on integrated blood pressure control

Haroon-Ur Rashid

Intravenous clevidipine for management of hypertension

Alma Rivera, Elsa Montoya, Joseph Varon

Intravenous clevidipine for management of hypertension

Alma Rivera,Elsa Montoya,Joseph Varon

Update on the role of candesartan in the optimal management of hypertension and cardiovascular risk reduction

Ikechi G Okpechi,Brian L Rayner

Is tetrahydrobiopterin a therapeutic option in diabetic hypertensive patients?

Alberto Francisco Rubio-Guerra,Hilda Vargas-Robles,Luz Maria Ramos-Brizuela,et al

Optimal management of hypertension in elderly patients

Maria Czarina Acelajado

Impact of olmesartan on blood pressure, endothelial function, and cardiovascular outcomes

Eduardo Pimenta,Suzanne Oparil

Critical appraisal and pooled analysis of telmisartan alone or in combination with hydrochlorothiazide for achieving blood pressure goals

Satoshi Morimoto,Nobuyuki Takahashi,Tatsuyori Morita,et al

Go




©2008-2020 OALib, Inc | Public user content licensed CC-BY 4.0 unless otherwise specified. OALib ISSN Online: 2333-9721 OALib ISSN Print: 2333-9705